Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MB-108 by Mustang Bio for Recurrent Malignant Glioma: Likelihood of Approval
MB-108 is under clinical development by Mustang Bio and currently in Phase I for Recurrent Malignant Glioma. According to GlobalData,...